TickrTrends RMD fair value analysis

QAN shares: your next growth investment?

raskmedia.com.au · 2026-09-07

The Qantas Airways Ltd (ASX:QAN) share price and Resmed CDI (ASX:RMD) share price are in focus in 2026. Here's how you could put a value on them.

TickrTrends take: RespiMed (RMD) operates in the Healthcare sector where TickrTrends currently identifies it as undervalued based on its derived analysis. The valuation assessment suggests that investors focused on fundamental value metrics may find the current pricing presents an opportunity relative to the company's underlying metrics. Readers monitoring RMD's valuation should track how the company's financial performance and market conditions evolve relative to this undervalued positioning.

Read the full story at raskmedia.com.au →

Is RMD undervalued? See TickrTrends' fair value analysis →